Ertumaxomab
|
WikiDoc Resources for Ertumaxomab |
|
Articles |
|---|
|
Most recent articles on Ertumaxomab Most cited articles on Ertumaxomab |
|
Media |
|
Powerpoint slides on Ertumaxomab |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Ertumaxomab at Clinical Trials.gov Clinical Trials on Ertumaxomab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Ertumaxomab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Ertumaxomab Discussion groups on Ertumaxomab Patient Handouts on Ertumaxomab Directions to Hospitals Treating Ertumaxomab Risk calculators and risk factors for Ertumaxomab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Ertumaxomab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Ertumaxomab (marketed under the brand name Rexomun®) is a rat-murine hybrid monoclonal antibody which it's used to treat some cancers.
Template:Rat-murinehybridmonoclonals
Template:WH
Template:WS